(Press-News.org) Cognitive behavioral therapy is a widely used nonpharmacologic treatment for insomnia disorders and an analysis of the medical literature suggests it also can work for patients whose insomnia is coupled with psychiatric and medical conditions, according to an article published online by JAMA Internal Medicine.
Previous meta-analyses have suggested that cognitive behavioral therapy for insomnia can improve sleep, although many of these studies excluded individuals with co-existing psychiatric and medical conditions.
Jason C. Ong, Ph.D., of Rush University Medical Center, Chicago, and coauthors reviewed medical literature to examine the efficacy of cognitive behavioral therapy for insomnia in patients with psychiatric conditions (including alcohol dependence, depression and post-traumatic stress disorder) and/or medical conditions (including chronic pain, cancer and fibromyalgia). The authors included 37 studies with data from 2,189 participants in their final analysis.
The meta-analysis by the authors found that, overall, cognitive behavioral therapy for insomnia was associated with reducing insomnia symptoms and sleep disturbances in individuals with coexisting conditions. At posttreatment evaluation about twice the percentage patients who received cognitive behavioral therapy for insomnia were in remission from insomnia compared those patients in control or comparison groups.
The therapy also was associated with positive effects on coexisting illness outcomes but the extent of that symptom improvement was determined by which type of coexisting illness patients had. Individuals with psychiatric disorders had larger changes than those with medical conditions, according to the analysis results. The authors note sleep disturbances may be more strongly associated with cognitive-emotional symptoms than physical symptoms, so reducing sleep disturbance could have a stronger effect on psychiatric illness.
"These findings provide empirical support for the recommendation of using CBT-I (cognitive behavioral therapy for insomnia) as the treatment of choice for comorbid insomnia disorders," the study concludes.
(JAMA Intern Med. Published online July 6, 2015. doi:10.1001/jamainternmed.2015.3006. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor's Note: An author made a conflict of interest disclosure. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Commentary: Treating Insomnia in Context of Medical, Psychiatric Comorbidities
In a related commentary, Michael A. Grandner, Ph.D., M.T.R., and Michael L. Perlis, Ph.D., of the University of Pennsylvania, Philadelphia, write: "This meta-analysis demonstrates that CBT-I is an effective treatment for insomnia even in the context of potentially overshadowing medical and psychiatric conditions. ... Further research is needed to better understand (1) treatment response with CBT-I in comorbid insomnia; (2) what components of CBT-I work best for comorbid insomnia; (3) to what extent CBT-I has effects on severity of and tolerance for noninsomnia symptoms; (4) the role of insomnia treatment in other chronic health conditions, such as obesity and cardiometabolic disease; and (5) the role of insomnia as an important indicator of health and functioning."
(JAMA Intern Med. Published online July 6, 2015. doi:10.1001/jamainternmed.2015.3015. Available pre-embargo to the media at http://media.jamanetwork.com.)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
INFORMATION:
Media Advisory: To contact corresponding author Jason C. Ong, Ph.D., call Deb Song at 312-942-0588 or email Deb_Song@rush.edu. To contact corresponding commentary author Michael A. Grandner, Ph.D., M.T.R., call Greg Richter at 215-614-1937 or email greg.richter@uphs.upenn.edu.
To place an electronic embedded link in your story: Links will be live at the embargo time: http://archinte.jamanetwork.com/article.aspx?doi=10.1001/jamainternmed.2015.3006 and http://archinte.jamanetwork.com/article.aspx?doi=10.1001/jamainternmed.2015.3015
MADISON - The newfound ability of a protein of the intestines and lungs to distinguish between human cells and the cells of bacterial invaders could underpin new strategies to fight infections.
Writing this week (July 6, 2015) in the journal Nature Structural and Molecular Biology, a team led by University of Wisconsin-Madison Professor Laura Kiessling describes the knack of a human protein known as intelectin to distinguish between our cells and those of the disease-causing microbes that invade our bodies.
"This has the potential to change the game in terms of how ...
Studying brain scans and cerebrospinal fluid of healthy adults, scientists have shown that changes in key biomarkers of Alzheimer's disease during midlife may help identify those who will develop dementia years later, according to new research.
The study, at Washington University School of Medicine in St. Louis, is published July 6 in JAMA Neurology.
"It's too early to use these biomarkers to definitively predict whether individual patients will develop Alzheimer's disease, but we're working toward that goal," said senior author Anne Fagan, PhD, a professor of neurology. ...
A blood-borne molecule that increases in abundance as we age blocks regeneration of brain cells and promotes cognitive decline, suggests a new study by researchers at UC San Francisco and Stanford School of Medicine.
The molecule in question, known as beta-2 microglobulin, or B2M, is a component of a larger molecule called MHC I (major histocompatibility complex class I), which plays a major role in the adaptive immune system. A growing body of research indicates that the B2M-MHC I complex, which is present in all cells in the body except red blood cells and plasma cells, ...
What gives plastic objects their flexibility and reduces their brittleness is the concentration of plasticiser. For example, a chemical solvent of the phthalate family called DOP is often used. The trouble is there are concerns that phthalates present health risks. So there is a demand for more alternatives. Now, scientists from China have examined the effect of using DEHHP, a new eco-friendly plasticiser, used in combination with PVC. For a plasticiser to work, there has to be adequate hydrogen bonding with the plastic. By combining experiments and simulations, the team ...
Nearly 800 million people worldwide don't have access to safe drinking water, and some 2.5 billion people live in precariously unsanitary conditions, according to the Centers for Disease Control and Prevention. Together, unsafe drinking water and the inadequate supply of water for hygiene purposes contribute to almost 90% of all deaths from diarrheal diseases -- and effective water sanitation interventions are still challenging scientists and engineers.
A new study published in Nature Nanotechnology proposes a novel nanotechnology-based strategy to improve water filtration. ...
Optogenetics techniques, which allow scientists to map and control nerve cells using light stimulation, are being used to study neural circuits in the brain with unprecedented precision. This revolutionary technology relies on light-sensitive proteins such as channelrhodopsins, and researchers at UC Santa Cruz have now determined the molecular mechanism involved in the light-induced activation of one of these proteins.
The new findings, published July 3 in two papers in the Journal of Biological Chemistry, can help scientists create tailor-made proteins optimized for ...
Evolutionary change in a gene resurrected in the lab from the extinct woolly mammoth altered the gene's temperature sensitivity and likely was part of a suite of adaptations that allowed the mammoth to survive in harsh arctic environments, according to new research. In a study published in Cell Reports on July 2, 2015, researchers determined the whole-genome sequence of two woolly mammoths and three modern Asian elephants, predicted the function of genetic changes found only in the mammoths, and then experimentally validated the function of a woolly mammoth gene reconstructed ...
An international team, led by a University of Adelaide genetics expert, has made a breakthrough discovery which is expected to help thousands of young girls worldwide who are suffering from a rare yet debilitating form of epilepsy.
Professor Jozef Gecz, from the University of Adelaide's Robinson Research Institute, was a key player in identifying the responsible gene and mutations in this female-only epileptic syndrome, in 2008.
In breakthrough research published in Oxford Journals, Human Molecular Genetics, Professor Gecz has now found a treatment for this disorder. ...
(PHILADELPHIA) -- Transfer RNAs (tRNAs) are ancient molecules and indispensable components of all living cells - they are found in all three kingdoms of life i.e., in archaea, bacteria and eukaryotes. In a cell, they are part of the machinery that translates messenger RNA (mRNA) sequences into amino acid sequences.
In recent years advances in sequencing technology have enabled detailed investigations of the RNA molecules that are active in a cell. A study published July 6th in the journal Oncotarget reports on a newly discovered category of tRNA fragments as well as ...
Andrew Hicks from the Museum of Natural History at the University of Colorado and his team discovered a previously unknown leafhopper species in the New Jersey Pine Barrens, located just east of the megalopolis that extends from New York City to Washington, DC. This was the first time an insect has been reported from the state-listed threatened pinebarren smokegrass, Muhlenbergia torreyana. The study can be found in the open-access journal ZooKeys.
The discovery was made with the help of Dr. Gerry Moore of the Natural Resources Conservation Service in Greensboro, NC, ...
